Silo Pharma shareholders approved authorized common share increase at annual meeting

Silo Pharma held its annual shareholder meeting on Aug. 14, 2026.

• Shareholders backed a charter amendment raising authorized common stock to 250,000,000 shares from 6,666,667 shares.
• The company executed that decision by filing a certificate of amendment to its articles of incorporation on Aug. 14, 2026.
• Investors ratified Salberg & Company, P.A. as independent registered public accounting firm for the fiscal year ending Dec. 31, 2026.
• Shareholders also authorized adjournment of the meeting if needed to solicit additional proxies.